According to Mochida Pharmaceutical's latest financial reports the company's current earnings are S$0.70 Billion. In 2023 the company made an earning of S$42.58 Million a decrease over its 2022 earnings that were of S$0.11 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Year | Earnings | Change |
---|---|---|
2024 (TTM) | S$57.32 M | 34.62% |
2023 | S$42.58 M | -64.19% |
2022 | S$0.11 B | -27.29% |
2021 | S$0.16 B | 11.29% |
2020 | S$0.14 B | 73% |
2019 | S$84.93 M | -43.7% |
2018 | S$0.15 B | 16.22% |
2017 | S$0.12 B | -22.22% |
2016 | S$0.16 B | 9.35% |
2015 | S$0.15 B | 4.67% |
2014 | S$0.14 B | -29.65% |
2013 | S$0.20 B | -3.02% |
2012 | S$0.21 B | 9.42% |
2011 | S$0.19 B | -1.02% |
2010 | S$0.19 B | -12.24% |
2009 | S$0.22 B |